ORGO Organogenesis Holdings Inc. - Class A

Organogenesis Holdings Inc. is a leading regenerative medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care, and surgical and sports medicine markets.

$9.82  +0.28 (2.94%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/05/2017
Outstanding shares:  128,644,021
Average volume:  871,640
Market cap:   $1,227,263,960
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68621F102
ISIN:        US68621F1021
Sedol:      BF2KYH7
Valuation   (See tab for details)
PE ratio:   20.47
PB ratio:   6.68
PS ratio:   2.75
Return on equity:   32.62%
Net income %:   13.82%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy